Lataa...

Intravitreal ranibizumab in choroidal neovascularisation due to multifocal choroiditis and panuveitis syndrome

We report the use of intravitreal ranibizumab as initial and only treatment in a case of peripapillary choroidal neovascularisation (CNV) in a patient with multifocal choroiditis and panuveitis (MCP) syndrome. A 54-year-old woman presented with sudden reduced vision in the right eye of 2 weeks durat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Dardabounis, Doukas, Alvanos, Efstratios, Gatzioufas, Zisis, Panos, Georgios D
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2013
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736297/
https://ncbi.nlm.nih.gov/pubmed/23867878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2013-009572
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!